Health & Fitness
Fri, June 15, 2012Thu, June 14, 2012Wed, June 13, 2012Tue, June 12, 2012Mon, June 11, 2012Sat, June 9, 2012Fri, June 8, 2012Thu, June 7, 2012Wed, June 6, 2012Tue, June 5, 2012Mon, June 4, 2012Sat, June 2, 2012Fri, June 1, 2012Thu, May 31, 2012Calendar of Events - Report Highlights Valeant Pharmaceuticals Int (USA) and Zimmer Holdings, Inc.
//health-fitness.news-articles.net/content/2012/ .. maceuticals-int-usa-and-zimmer-holdings-inc.html
Published in Health and Fitness on Friday, June 8th 2012 at 6:06 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
June 08, 2012 09:00 ET
Calendar of Events - Report Highlights Valeant Pharmaceuticals Int (USA) and Zimmer Holdings, Inc.
HONG KONG--(Marketwire - Jun 8, 2012) - Today, [ www.BrightonMarkets.com ] announced new reports highlighting Valeant Pharmaceuticals Int (USA) (
With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Brighton Markets is releasing new coverage on Valeant Pharmaceuticals Int (USA) for its current position within the healthcare industry. Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. It operates in five business segments: U.S. Neurology and Other, U.S. Dermatology, Canada and Australia, Branded Generics - Europe and Branded Generics -Latin America. The full research report on Valeant Pharmaceuticals Int (USA) (
Brighton Markets has released research on Zimmer Holdings, Inc. for its changing role within the healthcare industry. Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. The full research report on Zimmer Holdings, Inc. (
About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.